First Step Towards Switching Off Breast Cancer And Leukaemia

[News]

Australian scientists have identified a way to 'switch off' a molecule, a key player in the molecular processes that trigger breast cancer and certain forms of leukaemia. The molecule, known as Gab2, operates downstream of a major breast cancer oncogene, HER2, the target of the drug Herceptin.

More... (http://www.medicalnewstoday.com/articles/117642.php)